User profiles for Pierre Larochelle
 | Pierre Larochelleprofesseur de pharmacologie, université d Montréal Verified email at ircm.qc.ca Cited by 10268 |
Adverse events associated with prescription drug cost-sharing among poor and elderly persons
…, R Perreault, P McLeod, A Huang, P Larochelle… - Jama, 2001 - jamanetwork.com
ContextRising costs of medications and inequities in access have sparked calls for drug policy
reform in the United States and Canada. Control of drug expenditures by prescription cost-…
reform in the United States and Canada. Control of drug expenditures by prescription cost-…
Hypertension Canada's 2016 Canadian hypertension education program guidelines for blood pressure measurement, diagnosis, assessment of risk, prevention, and …
…, JM Boulanger, A Prebtani, P Larochelle… - Canadian Journal of …, 2016 - Elsevier
Hypertension Canada's Canadian Hypertension Education Program Guidelines Task Force
provides annually updated, evidence-based recommendations to guide the diagnosis, …
provides annually updated, evidence-based recommendations to guide the diagnosis, …
The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of …
…, JM Boulanger, A Prebtani, P Larochelle… - Canadian Journal of …, 2015 - Elsevier
The Canadian Hypertension Education Program reviews the hypertension literature annually
and provides detailed recommendations regarding hypertension diagnosis, assessment, …
and provides detailed recommendations regarding hypertension diagnosis, assessment, …
[HTML][HTML] The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and …
…, JG Howlett, JM Boulanger, P Larochelle… - Canadian Journal of …, 2014 - Elsevier
Herein, updated evidence-based recommendations for the diagnosis, assessment, prevention,
and treatment of hypertension in Canadian adults are detailed. For 2014, 3 existing …
and treatment of hypertension in Canadian adults are detailed. For 2014, 3 existing …
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2–therapy
…, EL Schiffrin, M Ruzicka, P Larochelle… - Canadian Journal of …, 2010 - Elsevier
Objective To update the evidence-based recommendations for the prevention and treatment
of hypertension in adults for 2010. Options and outcomes For lifestyle and pharmacological …
of hypertension in adults for 2010. Options and outcomes For lifestyle and pharmacological …
The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of …
…, JG Howlett, JM Boulanger, P Larochelle… - Canadian Journal of …, 2013 - Elsevier
We updated the evidence-based recommendations for the diagnosis, assessment, prevention,
and treatment of hypertension in adults for 2013. This year's update includes 2 new …
and treatment of hypertension in adults for 2013. This year's update includes 2 new …
The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of …
…, JG Howlett, JM Boulanger, P Larochelle… - Canadian Journal of …, 2012 - Elsevier
We updated the evidence-based recommendations for the diagnosis, assessment, prevention,
and treatment of hypertension in adults for 2012. The new recommendations are: (1) use …
and treatment of hypertension in adults for 2012. The new recommendations are: (1) use …
Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension.
EL Schiffrin, LY Deng, P Larochelle - Hypertension, 1994 - Am Heart Assoc
Seventeen male untreated mild essential hypertensive patients aged 41 +/- 2 years agreed
to participate in a double-blind randomized trial to test the effects of antihypertensive …
to participate in a double-blind randomized trial to test the effects of antihypertensive …
Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial
…, X Girerd, K Jamerson, P Larochelle… - Journal of …, 2006 - journals.lww.com
Objective To test for the first time the hypothesis that treatment of hypertensive patients at
high cardiovascular risk with the angiotensin-receptor blocker (ARB) valsartan prevents new-…
high cardiovascular risk with the angiotensin-receptor blocker (ARB) valsartan prevents new-…
Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study
…, S Kjeldsen, R Kolloch, P Larochelle… - Journal of …, 2001 - journals.lww.com
Background The Hypertension Optimal Treatment (HOT) Study has provided information about
cardiovascular events in 18 790 hypertensives, subjected to pronounced blood pressure (…
cardiovascular events in 18 790 hypertensives, subjected to pronounced blood pressure (…